Keyphrases
Randomized Controlled Trial
100%
Pooled Analysis
100%
Tiotropium
100%
Placebo
55%
Hazard Ratio
44%
Chronic Obstructive Pulmonary Disease
33%
Forced Expiratory Volume in 1 Second (FEV1)
22%
Hospitalization Rate
22%
Hospitalization
22%
Exacerbation Rate
22%
Randomized Placebo-controlled Trial
11%
Clinical Trials
11%
Antibiotics
11%
New Onset
11%
Acute Exacerbation of COPD (AECOPD)
11%
Respiratory Symptoms
11%
Delay Time
11%
Non-associated
11%
Systemic Corticosteroids
11%
Inhaled Corticosteroid Therapy
11%
Disease-related
11%
Pharmacology, Toxicology and Pharmaceutical Science
Randomized Controlled Trial
100%
Placebo
100%
Chronic Obstructive Lung Disease
66%
Clinical Trial
16%
Antibiotics
16%
Disease Exacerbation
16%
Biochemistry, Genetics and Molecular Biology
Randomized Controlled Trial
100%
Forced Expiratory Volume
100%
Clinical Trial
50%
Immunology and Microbiology
Forced Expiratory Volume
100%